Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jennifer L Hafterson"'
Autor:
Mary S, Potts, Jennifer L, Hafterson
Publikováno v:
Journal of registry management. 43(2)
Historically, newly hired staff members were trained using a labor intensive one-on-one strategy and experienced staff participated in monthly education meetings. With the ever-expanding data collection requirements and guideline changes, helping eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73bf833432311cf61b81431c756522ad
https://pubmed.ncbi.nlm.nih.gov/27556848
https://pubmed.ncbi.nlm.nih.gov/27556848
Publikováno v:
Journal of registry management. 43(2)
Integral parts of the Seattle-Puget Sound's Cancer Surveillance System registry's continuous improvement model include the incorporation of SEER*Educate into its training program for all staff and analyzing assessment results using the Abstracting Qu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::959730e2553b2f942e5faddf637e83b6
https://pubmed.ncbi.nlm.nih.gov/27556839
https://pubmed.ncbi.nlm.nih.gov/27556839
Autor:
Mary S. Potts, Ralph W. Aye, Mary Atwood, J. David Beatty, Jennifer L Hafterson, Mariko Adachi, Candy Bonham
Publikováno v:
American journal of surgery. 201(5)
Background Cancer Program Practice Profile Reports (CP 3 R), established by the Commission on Cancer, are based on 6 guidelines for breast and colorectal cancer care using cancer registry data. The long-term goal is the use of cancer registry data fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3ae0032a31d4333dadcf07bda4ceb58
https://pubmed.ncbi.nlm.nih.gov/21545915
https://pubmed.ncbi.nlm.nih.gov/21545915
Autor:
Donna Morrell, Lynn G. Ries, Vivien W. Chen, Linda C. Harlan, Mary S. Potts, Brenda K. Edwards, Christopher I. Li, Dennis Deapen, Marsha E. Reichman, Amanda I. Phipps, Xiao-Cheng Wu, Sean F. Altekruse, Jennifer L Hafterson
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(1)
The clinical importance of human epidermal growth factor receptor-2 (HER2) in breast cancer is now clearly established, given that expression of this tumor marker is used to guide therapy and as a prognostic indicator. Despite its now routine evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b7263b3c70d1db521a8d172572a1de
https://pubmed.ncbi.nlm.nih.gov/20056633
https://pubmed.ncbi.nlm.nih.gov/20056633